Kite Pharma Wants Fed. Circ. To Nix Juno's $1.2B Patent Win
By Tiffany Hu · September 1, 2020, 9:46 PM EDT
Gilead unit Kite Pharma is asking the Federal Circuit to wipe out a $1.2 billion judgment in Juno Therapeutics Inc.'s favor in a patent case over Kite's cancer treatment Yescarta, saying...
To view the full article, register now.